BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18063677)

  • 1. Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.
    Lichtenauer UD; Shapiro I; Geiger K; Quinkler M; Fassnacht M; Nitschke R; Rückauer KD; Beuschlein F
    Endocrinology; 2008 Mar; 149(3):1314-22. PubMed ID: 18063677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidogenic acute regulatory (StAR)-directed immunotherapy protects against tumor growth of StAR-expressing Sp2-0 cells in a rodent adrenocortical carcinoma model.
    Ortmann D; Hausmann J; Beuschlein F; Schmenger K; Stahl M; Geissler M; Reincke M
    Endocrinology; 2004 Apr; 145(4):1760-6. PubMed ID: 14715709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resorcylic acid lactone L-783,277 inhibits the growth of the human adrenal cancer cell line H295R in vitro.
    Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Altmann KH; Hofmann T; Stepien H
    Int J Immunopathol Pharmacol; 2009; 22(4):889-95. PubMed ID: 20074452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
    Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H
    Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells.
    Liu J; Li XD; Ora A; Heikkilä P; Vaheri A; Voutilainen R
    J Mol Endocrinol; 2004 Oct; 33(2):511-22. PubMed ID: 15525605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.
    Lichtenauer UD; Shapiro I; Osswald A; Meurer S; Kulle A; Reincke M; Riepe F; Beuschlein F
    Horm Metab Res; 2013 Feb; 45(2):124-9. PubMed ID: 23111829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor formation and drug resistance properties of human glioblastoma side population cells.
    Chen D
    Mol Med Rep; 2015 Jun; 11(6):4309-14. PubMed ID: 25633829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.
    Johnsen IK; Kappler R; Auernhammer CJ; Beuschlein F
    Cancer Res; 2009 Jul; 69(14):5784-92. PubMed ID: 19584291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
    Delhanty PJ; van Koetsveld PM; Gauna C; van de Zande B; Vitale G; Hofland LJ; van der Lely AJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of a human adrenocortical carcinoma xenograft model.
    Logié A; Boudou P; Boccon-Gibod L; Baudin E; Vassal G; Schlumberger M; Le Bouc Y; Gicquel C
    Endocrinology; 2000 Sep; 141(9):3165-71. PubMed ID: 10965887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
    Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells.
    Lin X; Takemori H; Katoh Y; Doi J; Horike N; Makino A; Nonaka Y; Okamoto M
    Mol Endocrinol; 2001 Aug; 15(8):1264-76. PubMed ID: 11463852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
    Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
    Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
    Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.
    Komuro H; Saihara R; Shinya M; Takita J; Kaneko S; Kaneko M; Hayashi Y
    J Pediatr Surg; 2007 Dec; 42(12):2040-5. PubMed ID: 18082704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor initiating potential of side population cells in human gastric cancer.
    Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
    Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 inhibits the maturation of pro-insulin-like growth factor-II (Pro-IGF-II) and the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in the human adrenocortical tumor cell line NCI-H295R.
    Boulle N; Gicquel C; Logié A; Christol R; Feige JJ; Le Bouc Y
    Endocrinology; 2000 Sep; 141(9):3127-36. PubMed ID: 10965883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
    Betz MJ; Shapiro I; Fassnacht M; Hahner S; Reincke M; Beuschlein F;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3886-96. PubMed ID: 15886257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.